Exelixis (EXEL) Cash from Operations (2010 - 2026)
Exelixis (EXEL) recorded Cash from Operations of $307.74 million in Q2 2027, up 528.1% from $48.99 million a year earlier and up 22.2% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Cash from Operations (2010 - 2026) Analysis & Trends
On a TTM basis, Exelixis' Cash from Operations came in at $1.18 billion as of Jul 3, 2026, up 53.3% year-over-year; for FY2026, it was $884.27 million, up 26.3% from FY2025.
- Annual Cash from Operations has a five-year compound annual growth rate of 17.1% (FY2021 to FY2026).
- Across earlier years, Cash from Operations came in at $699.97 million in FY2025, $333.32 million in FY2023 (-8.1%) and $362.61 million in FY2022 (-9.5%).
- Quarterly Cash from Operations has ranged from $48.99 million in Q2 2026 to $333.52 million in Q4 2026 over the past five years.
- On a year-over-year basis, Cash from Operations has increased for four consecutive quarters, with growth averaging 123.5% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $251.85 million (Q1 2027), $333.52 million (Q4 2026) and $290.32 million (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 307.74 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 307.74 Mn |
| Apr 3, 2026 | 251.85 Mn |
| Jan 2, 2026 | 333.52 Mn |
| Oct 3, 2025 | 290.32 Mn |
| Jul 4, 2025 | 48.99 Mn |
| Apr 4, 2025 | 211.44 Mn |
| Jan 3, 2025 | 240.26 Mn |
| Sep 27, 2024 | 271.34 Mn |
| Jun 28, 2024 | 119.55 Mn |
| Mar 29, 2024 | 68.82 Mn |
| Dec 29, 2023 | 10.57 Mn |
| Sep 29, 2023 | 117.37 Mn |
| Jun 30, 2023 | 120.98 Mn |
| Mar 31, 2023 | 84.41 Mn |
| Dec 30, 2022 | 73.69 Mn |
| Sep 30, 2022 | 110.07 Mn |
| Jul 1, 2022 | 31.13 Mn |
| Apr 1, 2022 | 147.72 Mn |
| Dec 31, 2021 | 96.45 Mn |
| Oct 1, 2021 | 83.31 Mn |
API Access
Exelixis Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();